Evidence map›Paper›PMID 33203961›Full record

ArticleScientific reports2020

Identification of synthetic chemosensitivity genes paired with BRAF for BRAF/MAPK inhibitors.

Kye Hwa Lee, Jinmin Goh, Yi-Jun Kim, Kwangsoo Kim

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kye Hwa LeeDepartment of Biomedical Informatics, Asan Medical Center, Seoul, 05505, South Korea. geffa@amc.seoul.kr.
Jinmin GohBiomedical Research Institute, Seoul National University Hospital, Seoul, 03080, South Korea.
Yi-Jun KimInstitute of Convergence Medicine, Ewha Womans University Mokdong Hospital, Seoul, 07985, South Korea.
Kwangsoo KimTransdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, 03080, South Korea. kksoo716@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular-targeted approaches are important for personalised cancer treatment, which requires knowledge regarding drug target specificity. Here, we used the synthetic lethality concept to identify candidate gene pairs with synergistic effects on drug responses. A synergistic chemo-sensitivity response was identified if a drug had a significantly lower half-maximal inhibitory concentration (IC

Indexed as

Cell Line, TumorCluster AnalysisDrug Resistance, NeoplasmDrug Screening Assays, AntitumorGene Expression Regulation, NeoplasticHumansInhibitory Concentration 50MAP Kinase Signaling SystemMutationNeoplasmsPharmacogeneticsProtein Kinase InhibitorsProto-Oncogene Proteins B-rafSurvival RateSynthetic Lethal MutationsProtein Kinase InhibitorsProto-Oncogene Proteins B-raf

Identifiers

PMID33203961
PMCPMC7672081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.